* Look out below — investors are meaningfully underpricing risk. * "Slugflation" remains our base case — accompanied by a revaluation (lower) in price earnings multiples. * The Fed may be between a rock and a hard place.…
Read in context ›Bristol-Myers Squibb Stock (BMY)
Track Bristol-Myers Squibb stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, TheStreet Pro portfolio activity, contributor watchlist signals, and Pro price levels.
BMY
Bristol-Myers Squibb
healthcare
$55.33
▲ +9.46 (+20.52%) past year
Market Cap
$116.95B
P/E Ratio
16.1x
1Y Return
+20.52%
EPS (TTM)
$3.56
Read the latest TheStreet Pro articles mentioning Bristol-Myers Squibb, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
51 articlesDaily Diary Mentions
1 mentionTrain Hundred and Two Is on the Wrong Track and Headed for You